Soc. Generale Discount Zert GSK!O.../ DE000SF0TA52 /
5/18/2022 8:25:36 AM | Chg.-0.02 | Bid5/18/2022 | Ask5/18/2022 | Underlying | Strike price | Expiration date | Option type |
---|---|---|---|---|---|---|---|
15.90EUR | -0.13% | 15.90 Bid Size: 750 |
16.00 Ask Size: 750 |
Glaxosmithkline PLC ... | - GBP | 6/24/2022 | Call |
GlobeNewswire
3/25
US Food and Drug Administration Revises Emergency Use Authorization for Sotrovimab Due to Omicron BA...
GlobeNewswire
2/28
Surface Oncology to Participate in Novel Immuno-Oncology Panel at Cowen’s 42nd Annual Health Care Co...
GlobeNewswire
2/28
Cullinan Oncology Expands Leadership Team and Board of Directors with Appointments of Jeffrey Jones,...
GlobeNewswire
2/10
Data Suggest Sotrovimab Retains Neutralizing Activity Against Omicron Subvariant BA.2
GlobeNewswire
12/14/2021
Preclinical Data Highlight the Significant Antigenic Shift of the Omicron SARS-CoV-2 Variant and its...